This site is intended for healthcare professionals only
LoginRegister

Health Bulletin 22/ June/ 2024

  |  
  • whatsapp
  • Telegram

Overview

Here are the top health news for the day:

Relief for FMGs: NMC shortens internship period to one year

After announcing its decision to not accept the compensatory certificates obtained by the Foreign Medical Graduates (FMGs), the National Medical Commission (NMC) has now modified its stand on the issue. Issuing a notice on 19.06.2024, the Undergraduate Medical Education Board (UGMEB) of the Commission clarified that all the medical graduates from abroad who have sufficiently compensated classes in physical onsite in lieu of the online classes and who have cleared the equivalent exam to MBBS i.e. the screening test, shall be eligible for one-year mandatory internship.

For more information, click on the link below:

NMC Relief: FMGs Who Have Sufficiently Compensated Classes In Physical Onsite In Lieu Of Online Classes Eligible For One Year Mandatory Internship


Centre notifies anti-paper leak law amid NEET, NET row: Rs 1 crore fine, jail up to 10 years for offenders

Amidst the raging row over alleged irregularities in NEET 2024 this year including paper leak, the Centre has brought a stringent law aiming to curb malpractices and irregularities in competitive examinations. The law entails provisions for a maximum jail term of 10 years and a fine of up to Rs 1 crore for offenders.

Nearly four months after President Dropadi Murmu gave assent to The Public Examinations (Prevention of Unfair Means) Act, 2024, the Personnel Ministry on Friday night issued a notification, saying the provisions of the law will come into force from June 21.

For more information, click on the link below:

Rs 1 Crore Fine, Upto 10 Years Jail For Offenders! Centre Notifies Law To Curb Exam Malpractices Amid NEET Row

Drug Safety Alert: Indian Pharmacopoeia Commission flags ADR linked to Meropenem

The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of May, has revealed that the carbapenem antibiotic Meropenem is linked with adverse drug reactions (ADRs) named Acute Generalized Exanthematous Pustulosis (AGEP).
In connection with the above, the Indian Pharmacopoeia Commission (IPC) has cautioned healthcare professionals to diligently monitor the potential occurrence of adverse drug reactions (ADRs) when administering Meropenem.
For more information click on the link below:

Speakers

Roshni Dhar

Roshni Dhar, a Mass com graduate with a soft corner for health happenings, joined Medical Dialogues as a news anchor in 2021. Inspired by her mother who is a gynaecologist, she likes to keep herself and the world updated on the occurring in the medical field. She covers various aspects of health news for MDTV at Medical Dialogues. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
X
sidekick